A share price of Lifecore Biomedical Inc [LFCR] is currently trading at $6.41, up 1.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LFCR shares have gain 12.07% over the last week, with a monthly amount drifted -3.68%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lifecore Biomedical Inc [NASDAQ: LFCR] stock has seen the most recent analyst activity on September 05, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $8. Previously, Barrington Research downgraded its rating to Mkt Perform on August 28, 2024. On March 20, 2023, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $2 on the stock.
Lifecore Biomedical Inc experienced fluctuations in its stock price throughout the past year between $3.68 and $7.99. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $6.41 at the most recent close of the market. An investor can expect a potential return of 1.4% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
Trailing Twelve Months sales for Lifecore Biomedical Inc [NASDAQ:LFCR] were 130.31M which represents -1.54% decline. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -2.64 and Total Capital is -0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.42.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.25 points at the first support level, and at 6.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.55, and for the 2nd resistance point, it is at 6.70.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Lifecore Biomedical Inc [NASDAQ:LFCR] is 2.71. Also, the Quick Ratio is 1.59, while the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 1.82, the price to book ratio is 106.40.
Transactions by insiders
Recent insider trading involved Josephs Paul, Chief Executive Officer, that happened on Jan 08 ’25 when 17000.0 shares were purchased. Former officer, Morberg John D completed a deal on Nov 20 ’24 to buy 10000.0 shares. Meanwhile, Former officer Morberg John D bought 30990.0 shares on Nov 11 ’24.
